ALPINE IMMUNE SCIENCES, INC. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2017 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Alpine Immune Sciences, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q2 2022.
  • Alpine Immune Sciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was $100K.
  • Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $155K, a 237% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $46K.
  • Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$214K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $100K Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-14
Q1 2019 $0 +$52K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q1 2018 -$52K -$52K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.